MassDevice.com +3 | The top 3 medtech stories for October 14, 2015

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.   3. HeartFlow’s CT-based FFR lowers costs, improves quality of life A non-invasive test of cardiac function made by HeartFlow lowered the cost of care and delivered improved quality of life scores compared to standard care, according to a study presented at the annual Transcatheter Cardiovascular Therapeutics conference. HeartFlow’s FFRCT test uses data from a standard CT scan to create a 3D map of the changes in blood flow as it passes across a coronary lesion. Results from the 584-patient Platform trial showed that the costs associated with planned angiography and the FFRCT procedure were 32% lower than the cost of angiography alone ($7,343 vs. $10,734). Read more 2. SynCardia pulls $28m IPO SynCardia Systems withdrew its plans for an initial public offering that was slated to fetch $27.5 million at the midpoint. “The registrant submits this request for withdrawal as it does not intend to pursue the contemplated public offering at this time,” the Tucson-based artificial heart maker said in an SEC filing. Syncardia had planned to float 2.5 million shares at $10 to $12 apiece. Read more 1. AtriCure closes $99m n...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 3 Source Type: news